IL123091A0 - Emulsion composition for eye drops - Google Patents

Emulsion composition for eye drops

Info

Publication number
IL123091A0
IL123091A0 IL12309196A IL12309196A IL123091A0 IL 123091 A0 IL123091 A0 IL 123091A0 IL 12309196 A IL12309196 A IL 12309196A IL 12309196 A IL12309196 A IL 12309196A IL 123091 A0 IL123091 A0 IL 123091A0
Authority
IL
Israel
Prior art keywords
eye drops
emulsion composition
emulsion
drops
eye
Prior art date
Application number
IL12309196A
Other languages
English (en)
Original Assignee
Wakamoto Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd
Publication of IL123091A0 publication Critical patent/IL123091A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
IL12309196A 1995-08-04 1996-08-05 Emulsion composition for eye drops IL123091A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP21830795 1995-08-04
PCT/JP1996/002187 WO1997005882A1 (fr) 1995-08-04 1996-08-05 Composition d'emulsion aqueuse pour collyres

Publications (1)

Publication Number Publication Date
IL123091A0 true IL123091A0 (en) 1998-09-24

Family

ID=16717797

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12309196A IL123091A0 (en) 1995-08-04 1996-08-05 Emulsion composition for eye drops

Country Status (12)

Country Link
US (1) US6132751A (zh)
EP (1) EP0844001B1 (zh)
KR (1) KR19990036175A (zh)
CN (1) CN1135984C (zh)
AU (1) AU697961B2 (zh)
CA (1) CA2228288A1 (zh)
DE (1) DE69620193T2 (zh)
ES (1) ES2173303T3 (zh)
HK (1) HK1017842A1 (zh)
IL (1) IL123091A0 (zh)
WO (1) WO1997005882A1 (zh)
ZA (1) ZA966579B (zh)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1020194A4 (en) * 1997-10-01 2003-05-21 Wakamoto Pharma Co Ltd OIL / WATER EMULSION COMPILATIONS
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
JP2005513097A (ja) * 2001-11-01 2005-05-12 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム ドライアイ治療方法および組成物
US20040115822A1 (en) * 2002-09-12 2004-06-17 Schapaugh Randal Lee Methods of measuring the dissolution rate of an analyte in a non-aqueous liquid composition
BR0306662A (pt) * 2002-10-18 2005-02-22 Joel S Echols Formulação lacrimal de três camadas
FR2856301B1 (fr) * 2003-06-23 2007-08-03 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile
US9364461B2 (en) 2006-12-21 2016-06-14 Santen Sas Process for manufacturing ophthalmic oil-in-water emulsions
KR20100031608A (ko) * 2007-06-26 2010-03-23 와카모토 세이야꾸 가부시끼가이샤 수성 조성물
DE102011013959A1 (de) 2011-03-14 2012-09-20 Kautex Textron Gmbh & Co. Kg Druckausgleichsventil für Kraftstoff- oder Nebenflüssigkeitsbehälter an einem KFZ
US8900626B2 (en) * 2011-06-20 2014-12-02 Senju Usa, Inc. Transdermal drug delivery system and method of using the same
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
TWI773641B (zh) 2015-05-08 2022-08-11 日商活效製藥股份有限公司 含有糖皮質類固醇(glucocorticoids)之奈米微粒子之水性懸浮液劑
US11065217B2 (en) 2017-01-27 2021-07-20 Temple University—Of the Commonwealth System of Higher Education Use of short chain fatty acids for the treatment and prevention of diseases and disorders
SG11201912393XA (en) * 2017-06-23 2020-01-30 Salvat Lab Sa An oil-in-water nanoemulsion composition of clobetasol
WO2019117252A1 (ja) * 2017-12-14 2019-06-20 参天製薬株式会社 2-アミノ-3-(4-ブロモベンゾイル)フェニル酢酸またはその塩を含有する点眼剤
MX2019010618A (es) * 2019-09-06 2021-11-30 Sophia Holdings S A De C V Composicion farmacéutica oftálmica, procesos de preparación y usos de las mismas.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440371A1 (fr) * 1978-10-31 1980-05-30 Fisons Ltd Nouveaux composes azotes heterocycliques, des compositions pharmaceutiques en contenant et des procedes pour les preparer
US4670185A (en) * 1982-07-19 1987-06-02 Lion Corporation Aqueous vesicle dispersion having surface charge
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
JPS6160620A (ja) * 1984-09-03 1986-03-28 Teijin Ltd ピログルタミン酸エステル類を含有する医薬品組成物
JPH0660101B2 (ja) * 1984-11-27 1994-08-10 参天製薬株式会社 クロベタゾン−17−ブチレ−トの水性製剤
JPS61249918A (ja) * 1985-04-26 1986-11-07 Yutaka Mizushima 点眼剤
JPS62270521A (ja) * 1986-05-16 1987-11-24 Green Cross Corp:The フルルビプロフエン眼投与製剤
IE63392B1 (en) * 1988-02-08 1995-04-19 Insite Vision Inc Ophthalmic suspensions
JP2617139B2 (ja) * 1988-03-09 1997-06-04 アルコン ラボラトリーズ インコーポレイテッド 局所的眼科用途の為のトブラマイシンとステロイドの組合わせ
JP2827295B2 (ja) * 1989-07-04 1998-11-25 大正製薬株式会社 ビタミンa類含有点眼剤
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
CA2142103C (en) * 1992-08-28 2003-07-08 Haim Aviv Submicron emulsions as ocular drug delivery vehicles
AU7668894A (en) * 1993-08-13 1995-03-14 Vitaphore Corporation Hydrogel-based microsphere drug delivery systems
US5693337A (en) * 1994-07-13 1997-12-02 Wakamoto Pharmaceutical Co., Ltd. Stable lipid emulsion
ES2094688B1 (es) * 1994-08-08 1997-08-01 Cusi Lab Manoemulsion del tipo de aceite en agua, util como vehiculo oftalmico y procedimiento para su preparacion.
US5767153A (en) * 1995-06-07 1998-06-16 Insite Vision Incorporated Sustained release emulsions

Also Published As

Publication number Publication date
ES2173303T3 (es) 2002-10-16
EP0844001B1 (en) 2002-03-27
ZA966579B (en) 1998-02-02
DE69620193T2 (de) 2002-10-31
DE69620193D1 (de) 2002-05-02
KR19990036175A (ko) 1999-05-25
EP0844001A1 (en) 1998-05-27
WO1997005882A1 (fr) 1997-02-20
AU697961B2 (en) 1998-10-22
CN1135984C (zh) 2004-01-28
US6132751A (en) 2000-10-17
HK1017842A1 (en) 1999-12-03
EP0844001A4 (en) 1998-11-18
AU6630396A (en) 1997-03-05
CN1196682A (zh) 1998-10-21
CA2228288A1 (en) 1997-02-20

Similar Documents

Publication Publication Date Title
HUP9802544A3 (en) Cable-sheathing composition
SG52651A1 (en) Composition
AU3772195A (en) Water-in-oil emulsion fertilizer compositions
GB9518033D0 (en) Composition
IL123091A0 (en) Emulsion composition for eye drops
GB2297601B (en) Mounting eye
IL119897A0 (en) Projecting images
EP0779097A4 (en) EMULSION COMPOSITION
HU9600352D0 (en) Bitumenous composition
GB2306616B (en) Mounting eye
EP0782882A4 (en) ALCOHOL OIL EMULSION COMPOSITION
AU6827794A (en) Water-in-oil emulsion compositions
AU7337496A (en) Eye drops
TW350327U (en) Eye mask
GB9722691D0 (en) Emulsion composition
AU5342498A (en) Difluprednate-containing ophthalmic o/w emulsion composition
GB9508323D0 (en) Composition
GB9610841D0 (en) Aqueous silane emulsion composition
EP0757075A3 (en) Polyaminotriazine composition
ZA965332B (en) Melosis regulating compounds
GB9511701D0 (en) Composition
AU124450S (en) Sunglasses
IL114379A0 (en) Ophthalmic compositions
CA76014S (en) Sunglasses
CA76117S (en) Sunglasses